GPO cleared to make its own Favipiravir tabletsThe path has been cleared for the Government Pharmaceutical Organization (GPO) to produce one million tablets a month of the antiviral medicine Favipiravir after the Department of Intellectual Property (DIP) rejected a request by a company to patent the drug here. The GPO is developing its own version of Favipiravir to boost the kingdom's supply and reduce dependence on imports. The GPO will only be allowed to sell its own Favipiravir tablets when its formula is approved by the FDA. It then expects to be able to produce at least one million tablets per month and then expand its capacity to meet the rising demand. Dr Withoon yesterday received a further one million doses of China's Sinovac vaccine at Suvarnabhumi Airport.

Source: Bangkok Post May 07, 2021 04:52 UTC